A fed­er­al judge has sus­pend­ed the Pen­tagon's des­ig­na­tion of WuXi AppTec as a com­pa­ny with al­leged ties to the Chi­nese mil­i­tary.

Judge James Boas­berg wrote...

Mass­a­chu­setts biotech Schol­ar Rock said it's pulling an em­bat­tled In­di­ana-based man­u­fac­tur­ing site from its ap­pli­ca­tion for a po­ten­tial new spinal mus­cu­lar at­ro­phy drug, af­ter the...

The FDA re­ject­ed ITM Iso­tope Tech­nolo­gies Mu­nich’s ra­dio­phar­ma­ceu­ti­cal agent for neu­roen­docrine tu­mors be­cause of man­u­fac­tur­ing is­sues, de­lay­ing a po­ten­tial chal­lenger to No­var­tis’ ap­proved drug Lu­tathera...

Bris­tol My­ers Squibb re­vealed plansfor a $2.3 bil­lion man­u­fac­tur­ing cam­pus in Hous­ton, part of the com­pa­ny's pledge last year to in­vest $40 bil­lion in...

From 2028 to 2032, gener­ic drug ap­pli­cants will con­tin­ue to see many of the same FDA re­view time­lines as they did over the last five...

Hims & Hers is lay­ing the ground­work to of­fer ac­cess to six banned con­sumer well­ness pep­tides,should the FDA lift re­stric­tions that pre­vent com­pound­ing phar­ma­cies...

Eli Lil­ly has sued six US com­pa­nies for sell­ing what they claim is the phar­ma gi­ant’s in­ves­ti­ga­tion­al di­a­betes and weight loss drug re­ta­tru­tide, which is...